170 related articles for article (PubMed ID: 15265190)
41. No effect of long-term valproate therapy on thyroid and parathyroid functions in children.
Caksen H; Dülger H; Cesur Y; Odabaş D; Tuncer O; Ataş B
Int J Neurosci; 2002 Nov; 112(11):1371-4. PubMed ID: 12625196
[TBL] [Abstract][Full Text] [Related]
42. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Yonsei Med J; 2004 Aug; 45(4):676-82. PubMed ID: 15344210
[TBL] [Abstract][Full Text] [Related]
43. Bone mineral density loss in ambulatory children with epilepsy in spite of using supplemental vitamin D in Southern Iran: a case-control study.
Inaloo S; Paktinat M; Saki F; Katibeh P; Nemati H; Dabbaghmanesh MH; Omrani GHR
J Bone Miner Metab; 2019 May; 37(3):537-544. PubMed ID: 30191457
[TBL] [Abstract][Full Text] [Related]
44. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
45. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
48. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
49. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
50. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
51. BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Lambrinoudaki I; Kaparos G; Armeni E; Alexandrou A; Damaskos C; Logothetis E; Creatsa M; Antoniou A; Kouskouni E; Triantafyllou N
Eur J Neurol; 2011 Jan; 18(1):93-8. PubMed ID: 20500803
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
53. Bone mineral density in children, adolescents, and young adults with epilepsy.
Coppola G; Fortunato D; Auricchio G; Mainolfi C; Operto FF; Signoriello G; Pascotto A; Salvatore M
Epilepsia; 2009 Sep; 50(9):2140-6. PubMed ID: 19486359
[TBL] [Abstract][Full Text] [Related]
54. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
55. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
56. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
Geda G; Caksen H; Içağasioğlu D
Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
[TBL] [Abstract][Full Text] [Related]
57. Determinants of low bone mineral density in children with epilepsy.
Fong CY; Kong AN; Noordin M; Poh BK; Ong LC; Ng CC
Eur J Paediatr Neurol; 2018 Jan; 22(1):155-163. PubMed ID: 29122496
[TBL] [Abstract][Full Text] [Related]
58. The effects of anorexia nervosa on bone metabolism in female adolescents.
Soyka LA; Grinspoon S; Levitsky LL; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 1999 Dec; 84(12):4489-96. PubMed ID: 10599707
[TBL] [Abstract][Full Text] [Related]
59. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
60. Bone mineral status in preterm-born children: assessment by dual-energy X-ray absorptiometry.
Hori C; Tsukahara H; Fujii Y; Kawamitsu T; Konishi Y; Yamamoto K; Ishii Y; Sudo M
Biol Neonate; 1995; 68(4):254-8. PubMed ID: 8580216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
